Agenus Return on Investment 2006-2020 | AGEN

Current and historical return on investment (ROI) values for Agenus (AGEN) over the last 10 years.
Agenus ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2020-03-31 $-0.12B $-0.18B 66.85%
2019-12-31 $-0.07B $-0.21B 41.54%
2019-09-30 $-0.09B $-0.20B 57.60%
2019-06-30 $-0.08B $-0.15B 58.61%
2019-03-31 $-0.06B $-0.11B 45.53%
2018-12-31 $-0.12B $-0.16B 103.55%
2018-09-30 $-0.12B $-0.12B 183.27%
2018-06-30 $-0.12B $-0.10B 793.44%
2018-03-31 $-0.13B $-0.10B -332.50%
2017-12-31 $-0.10B $0.07B -103.23%
2017-09-30 $-0.09B $0.07B -88.06%
2017-06-30 $-0.10B $0.12B -85.22%
2017-03-31 $-0.09B $0.14B -77.82%
2016-12-31 $-0.11B $0.09B -86.75%
2016-09-30 $-0.11B $0.11B -71.62%
2016-06-30 $-0.08B $0.14B -48.00%
2016-03-31 $-0.09B $0.16B -56.78%
2015-12-31 $-0.08B $0.19B -67.94%
2015-09-30 $-0.08B $0.19B -100.64%
2015-06-30 $-0.08B $0.10B -241.27%
2015-03-31 $-0.05B -728.57%
2014-12-31 $-0.04B $0.03B -614.29%
2014-09-30 $-0.03B -12800.00%
2014-06-30 $-0.03B -12400.00%
2014-03-31 $-0.03B -12000.00%
2013-12-31 $-0.03B $0.00B -714.29%
2013-09-30 $-0.02B -296.77%
2013-06-30 $-0.02B -158.49%
2013-03-31 $-0.02B $0.01B -103.90%
2012-12-31 $-0.01B $0.02B -32.56%
2012-09-30 $-0.01B $0.02B -40.00%
2012-06-30 $-0.01B $0.02B -38.36%
2012-03-31 $-0.01B $0.02B -38.71%
2011-12-31 $-0.02B $0.01B -135.71%
2011-09-30 $-0.02B $0.02B -120.63%
2011-06-30 $-0.02B $0.01B -200.00%
2011-03-31 $-0.02B $0.02B -142.86%
2010-12-31 $-0.02B $0.02B -135.38%
2010-09-30 $-0.02B $-0.01B -111.39%
2010-06-30 $-0.02B $0.03B -79.31%
2010-03-31 $-0.03B $0.03B -97.20%
2009-12-31 $-0.03B $0.03B -94.74%
2009-09-30 $-0.03B $0.03B -92.80%
2009-06-30 $-0.03B $0.02B -91.03%
2009-03-31 $-0.04B $0.03B -78.26%
2008-12-31 $-0.04B $0.04B -76.38%
2008-09-30 $-0.04B $0.05B -80.00%
2008-06-30 $-0.04B $0.06B -85.55%
2008-03-31 $-0.04B $0.05B -89.74%
2007-12-31 $-0.03B $0.03B -83.02%
2007-09-30 $-0.04B $0.04B -81.28%
2007-06-30 $-0.04B $0.04B -80.83%
2007-03-31 $-0.04B $0.05B -86.27%
2006-12-31 $-0.05B $0.06B -92.73%
2006-09-30 $-0.06B $0.04B -95.08%
2006-06-30 $-0.06B $0.05B -85.05%
2006-03-31 $-0.07B $0.07B -77.38%
2005-12-31 $-0.07B $0.08B -66.97%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.521B $0.150B
Agenus Inc., formerly known as Antigenics Inc., is engaged in the discovery, development and commercialization of immunotherapeutics for the treatment of life threatening and chronic medical conditions. Immunotherapeutics are drugs that work by modulating the immune system to fight diseases. The Company's product line includes Oncophage vaccine, a patient-specific therapeutic cancer vaccine. The Company is also developing Prophage, patient-specific therapeutic cancer vaccine; QS-21, vaccine adjuvant; and HerpV, a polyvalent off-the-shelf therapeutic heat shock protein-based vaccine for treatment of genital herpes which are all in the clinical testing stages. Agenus Inc. is headquartered in Lexington, Massachusetts.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $143.302B 15.56
Bristol Myers Squibb (BMY) United States $132.729B 11.09
Gilead Sciences (GILD) United States $87.217B 12.55
CSL (CSLLY) Australia $86.987B 0.00
Vertex Pharmaceuticals (VRTX) United States $70.523B 39.53
Regeneron Pharmaceuticals (REGN) United States $69.539B 26.81
Illumina (ILMN) United States $56.178B 57.73
Biogen (BIIB) United States $43.487B 7.44
Seattle Genetics (SGEN) United States $28.782B 0.00
Moderna (MRNA) United States $27.508B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $23.913B 0.00
Alexion Pharmaceuticals (ALXN) United States $22.463B 9.36
Genmab (GMAB) Denmark $22.342B 18.38
BioMarin Pharmaceutical (BMRN) United States $21.666B 196.41
Incyte (INCY) United States $21.468B 0.00
Genmab (GNMSF) Denmark $20.660B 61.34
BeiGene (BGNE) Cayman Islands $18.676B 0.00
BioNTech SE (BNTX) Germany $18.578B 0.00
Alnylam Pharmaceuticals (ALNY) United States $16.814B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.496B 70.16
Exact Sciences (EXAS) United States $14.205B 0.00
Galapagos (GLPG) Belgium $12.015B 35.34
Sarepta Therapeutics (SRPT) United States $11.973B 0.00
Horizon Therapeutics Public (HZNP) Ireland $11.674B 28.73
QIAGEN (QGEN) Netherlands $11.262B 32.75
ARGENX SE-ADR (ARGX) Netherlands $10.818B 0.00
Bio-Techne Corp (TECH) United States $10.517B 69.49
Immunomedics (IMMU) United States $9.751B 0.00
Novavax (NVAX) United States $8.294B 0.00
Guardant Health (GH) United States $8.056B 0.00
Repligen (RGEN) United States $7.923B 125.76
Ascendis Pharma (ASND) Denmark $7.272B 0.00
Exelixis (EXEL) United States $7.081B 24.83
ACADIA Pharmaceuticals (ACAD) United States $6.479B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $6.369B 15.84
CRISPR Therapeutics AG (CRSP) Switzerland $5.997B 185.78
Emergent Biosolutions (EBS) United States $5.832B 23.32
Vir Biotechnology (VIR) United States $5.631B 0.00
Acceleron Pharma (XLRN) United States $5.338B 0.00
Mirati Therapeutics (MRTX) United States $5.294B 0.00
Reata Pharmaceuticals (RETA) United States $4.909B 0.00
Adaptive Biotechnologies (ADPT) United States $4.786B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.662B 0.00
Zai Lab (ZLAB) China $4.422B 0.00
MorphoSys AG (MOR) Germany $4.231B 32.82
MyoKardia (MYOK) United States $4.207B 0.00
China Biologic Products (CBPO) China $4.186B 23.27
Global Blood Therapeutics (GBT) United States $4.112B 0.00
NeoGenomics (NEO) United States $4.027B 1274.33
Blueprint Medicines (BPMC) United States $3.966B 0.00
Amicus Therapeutics (FOLD) United States $3.723B 0.00
Halozyme Therapeutics (HALO) United States $3.693B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.471B 0.00
Bluebird Bio (BLUE) United States $3.378B 0.00
Arena Pharmaceuticals (ARNA) United States $3.090B 0.00
Inovio Pharmaceuticals (INO) United States $3.073B 0.00
Alkermes (ALKS) Ireland $2.864B 60.03
Principia Biopharma (PRNB) United States $2.762B 0.00
Insmed (INSM) United States $2.639B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.590B 0.00
Amarin (AMRN) Ireland $2.498B 0.00
Denali Therapeutics (DNLI) United States $2.474B 0.00
Fate Therapeutics (FATE) United States $2.429B 0.00
Twist Bioscience (TWST) United States $2.296B 0.00
PHARMA MAR SA (PHMMF) Spain $1.922B 0.00
Ligand Pharmaceuticals (LGND) United States $1.881B 73.24
Sorrento Therapeutics (SRNE) United States $1.870B 0.00
Viela Bio (VIE) United States $1.867B 0.00
UniQure (QURE) Netherlands $1.855B 0.00
I-Mab (IMAB) China $1.823B 0.00
Editas Medicine (EDIT) United States $1.622B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.589B 0.00
Mesoblast (MESO) Australia $1.568B 0.00
Eidos Therapeutics (EIDX) United States $1.545B 0.00
Sangamo Therapeutics (SGMO) United States $1.526B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.504B 0.00
Epizyme (EPZM) United States $1.399B 0.00
Zymeworks (ZYME) Canada $1.390B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.364B 0.00
Adverum Biotechnologies (ADVM) United States $1.347B 0.00
Revance Therapeutics (RVNC) United States $1.340B 0.00
Mersana Therapeutics (MRSN) United States $1.331B 0.00
Intra-Cellular Therapies (ITCI) United States $1.317B 0.00
Zealand Pharma (ZEAL) Denmark $1.289B 0.00
Cytokineticsorporated (CYTK) United States $1.286B 0.00
Zealand Pharma (ZLDPF) Denmark $1.276B 0.00
Coherus BioSciences (CHRS) United States $1.247B 8.71
NGM Biopharmaceuticals (NGM) United States $1.246B 0.00
Alector (ALEC) United States $1.238B 0.00
Arvinas (ARVN) United States $1.233B 0.00
REGENXBIO (RGNX) United States $1.233B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.217B 0.00
NantKwest (NK) United States $1.101B 0.00
Akcea Therapeutics (AKCA) United States $1.096B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.086B 0.00
Alcobra (ARCT) United States $1.076B 0.00
Beam Therapeutics (BEAM) United States $0.996B 0.00
Compugen (CGEN) Israel $0.986B 0.00
VBI Vaccines (VBIV) United States $0.939B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.932B 40.04
Intellia Therapeutics (NTLA) United States $0.915B 0.00
Arcus Biosciences (RCUS) United States $0.906B 0.00
Heska (HSKA) United States $0.904B 0.00
Myriad Genetics (MYGN) United States $0.900B 46.42
Athenex (ATNX) United States $0.866B 0.00
Retrophin (RTRX) United States $0.858B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.825B 0.00
Cara Therapeutics (CARA) United States $0.769B 0.00
Dynavax Technologies (DVAX) United States $0.748B 0.00
Vericel (VCEL) United States $0.744B 137.42
Intrexon (PGEN) United States $0.725B 0.00
Pharming Group (PHGUF) Netherlands $0.707B 16.14
Codexis (CDXS) United States $0.698B 0.00
Morphic Holding (MORF) United States $0.690B 0.00
Castle Biosciences (CSTL) United States $0.667B 0.00
Cellectis S.A (CLLS) France $0.667B 0.00
Frequency Therapeutics (FREQ) United States $0.656B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
ZIOPHARM Oncology Inc (ZIOP) United States $0.636B 0.00
MiMedx (MDXG) United States $0.611B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.594B 0.00
Kadmon Holdings (KDMN) United States $0.586B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.550B 4.71
Cue Biopharma (CUE) United States $0.538B 0.00
Anika Therapeutics (ANIK) United States $0.517B 22.61
Syndax Pharmaceuticals (SNDX) United States $0.509B 0.00
Athersys (ATHX) United States $0.503B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.500B 0.00
AnaptysBio (ANAB) United States $0.490B 0.00
Prothena (PRTA) Ireland $0.489B 0.00
MeiraGTx Holdings (MGTX) United States $0.485B 0.00
Kala Pharmaceuticals (KALA) United States $0.478B 0.00
UROGEN PHARMA (URGN) United States $0.462B 0.00
DBV Technologies S.A (DBVT) France $0.452B 0.00
Clovis Oncology (CLVS) United States $0.445B 0.00
AC Immune SA (ACIU) Switzerland $0.441B 0.00
Syros Pharmaceuticals (SYRS) United States $0.434B 0.00
Protagonist Therapeutics (PTGX) United States $0.432B 0.00
Albireo Pharma (ALBO) United States $0.423B 0.00
BioDelivery Sciences (BDSI) United States $0.420B 22.05
Avid Bioservices (CDMO) United States $0.419B 0.00
Puma Biotechnology (PBYI) United States $0.406B 0.00
Merus (MRUS) Netherlands $0.398B 0.00
Kamada (KMDA) Israel $0.394B 16.41
Prometic Life Sciences (LMNL) Canada $0.385B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.382B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.372B 0.00
ANI Pharmaceuticals (ANIP) United States $0.365B 7.10
PDL BioPharma (PDLI) United States $0.362B 318.00
Scholar Rock Holding (SRRK) United States $0.337B 0.00
MannKind (MNKD) United States $0.332B 0.00
Precision BioSciences (DTIL) United States $0.330B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.327B 0.00
Geron (GERN) United States $0.323B 0.00
CytomX Therapeutics (CTMX) United States $0.322B 0.00
WAVE Life Sciences (WVE) Singapore $0.314B 0.00
ChromaDex (CDXC) United States $0.311B 0.00
ADMA Biologics Inc (ADMA) United States $0.308B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.306B 0.00
Seres Therapeutics (MCRB) United States $0.285B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.280B 0.00
Starpharma Holdings (SPHRY) Australia $0.279B 0.00
OSMOTICA PHARM (OSMT) United States $0.276B 0.00
Menlo Therapeutics (MNLO) United States $0.270B 0.00
Affimed (AFMD) Germany $0.269B 0.00
Arbutus Biopharma (ABUS) United States $0.263B 0.00
Northwest Biotherapeutics (NWBO) United States $0.257B 0.00
Cellular Biomedicine (CBMG) United States $0.255B 0.00
Pluristem Therapeutics (PSTI) Israel $0.250B 0.00
Trevena (TRVN) United States $0.249B 0.00
NextCure (NXTC) United States $0.245B 0.00
Spero Therapeutics (SPRO) United States $0.241B 0.00
Abeona Therapeutics (ABEO) United States $0.239B 0.00
Dyadic (DYAI) United States $0.238B 0.00
Celldex Therapeutics (CLDX) United States $0.232B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.231B 0.00
Fortress Biotech (FBIO) United States $0.229B 0.00
Aduro Biotech (ADRO) United States $0.228B 0.00
Verastem (VSTM) United States $0.218B 0.00
Five Prime Therapeutics (FPRX) United States $0.216B 0.00
HOOKIPA Pharma (HOOK) United States $0.211B 0.00
Selecta Biosciences (SELB) United States $0.208B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.208B 9.70
IVERIC Bio (ISEE) United States $0.206B 0.00
Exicure (XCUR) United States $0.195B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.188B 0.00
Theratechnologies (THTX) Canada $0.186B 0.00
GENFIT S.A (GNFT) France $0.186B 0.00
XOMA (XOMA) United States $0.184B 0.00
Strongbridge Biopharma (SBBP) United States $0.183B 0.00
Sutro Biopharma (STRO) United States $0.180B 0.00
POXEL SA FRANCE (PXXLF) France $0.177B 0.00
Aptinyx (APTX) United States $0.172B 0.00
Aytu Bioscience (AYTU) United States $0.168B 0.00
Cerecor (CERC) United States $0.163B 0.00
VTv Therapeutics (VTVT) United States $0.159B 0.00
Bellus Health (BLU) Canada $0.158B 0.00
Liquidia Technologies (LQDA) United States $0.157B 0.00
Cidara Therapeutics (CDTX) United States $0.150B 0.00
Nicox SA (NICXF) France $0.146B 0.00
Eton Pharmaceuticals (ETON) United States $0.140B 0.00
Applied Genetic Technologies (AGTC) United States $0.136B 0.00
Celyad SA (CYAD) Belgium $0.135B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.134B 0.00
TELA Bio (TELA) United States $0.133B 0.00
Kindred Biosciences (KIN) United States $0.129B 0.00
Biofrontera AG (BFRA) Germany $0.126B 0.00
Oncobiologics (OTLK) United States $0.124B 0.00
Checkpoint Therapeutics (CKPT) United States $0.124B 0.00
Orgenesis (ORGS) United States $0.121B 0.00
Gritstone Oncology (GRTS) United States $0.119B 0.00
Lumos Pharma (LUMO) United States $0.117B 0.00
PHASEBIO PHARMA (PHAS) United States $0.115B 0.00
SESEN BIO, INC (SESN) United States $0.115B 0.00
Windtree Therapeutics (WINT) United States $0.115B 0.00
Enzo Biochem (ENZ) United States $0.114B 0.00
Cyclerion Therapeutics (CYCN) United States $0.106B 0.00
Vaccinex (VCNX) United States $0.105B 0.00
AIT Therapeutics (XAIR) United States $0.105B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.103B 0.00
AquaBounty Technologies (AQB) United States $0.098B 0.00
Cardiff Oncology (CRDF) United States $0.096B 0.00
ARAVIVE, INC (ARAV) United States $0.094B 0.00
Emmaus Life Sciences (EMMA) United States $0.093B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.089B 0.00
Cocrystal Pharma (COCP) United States $0.088B 0.00
Antibe Therapeutics (ATBPF) Canada $0.086B 0.00
Organovo Holdings (ONVO) United States $0.086B 0.00
DiaMedica Therapeutics (DMAC) United States $0.084B 0.00
Unum Therapeutics (UMRX) United States $0.084B 0.00
Adocia (ADOCY) France $0.080B 0.00
Stealth BioTherapeutics (MITO) United States $0.078B 0.00
Ecology Coatings (ABVC) United States $0.077B 0.00
Proteostasis Therapeutics (PTI) United States $0.077B 0.00
Synlogic (SYBX) United States $0.074B 0.00
Clearside Biomedical (CLSD) United States $0.074B 0.00
AnPac Bio-Medical Science (ANPC) China $0.071B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.069B 0.00
Idera Pharmaceuticals (IDRA) United States $0.067B 0.00
Bionano Genomics (BNGO) United States $0.066B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.065B 0.00
Soligenix (SNGX) United States $0.064B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.062B 0.00
Happiness Biotech Group (HAPP) China $0.062B 0.00
Catalyst Biosciences (CBIO) United States $0.062B 0.00
Edesa Biotech (EDSA) Canada $0.061B 0.00
Signal Genetics (MGEN) United States $0.059B 0.00
IMMURON (IMRN) Australia $0.055B 0.00
Vascular Biogenics (VBLT) Israel $0.055B 0.00
Prima BioMed (IMMP) Australia $0.052B 0.00
Apricus Biosciences (SEEL) United States $0.052B 0.00
CollPlant Holdings (CLGN) Israel $0.051B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.051B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.048B 0.00
Curis (CRIS) United States $0.043B 0.00
Spherix (AIKI) United States $0.039B 0.00
Chanticleer Holdings (SONN) United States $0.038B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
Advaxis (ADXS) United States $0.036B 0.00
Genetic Technologies (GENE) Australia $0.036B 0.00
Celsion (CLSN) United States $0.035B 0.00
Cesca Therapeutics (THMO) United States $0.034B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.034B 0.00
Pulmatrix (PULM) United States $0.034B 0.00
OvaScience (MLND) United States $0.033B 0.00
Acorda Therapeutics (ACOR) United States $0.030B 0.00
Forte Biosciences (FBRX) United States $0.030B 0.00
Alimera Sciences (ALIM) United States $0.030B 0.00
Novogen (KZIA) Australia $0.028B 0.00
Titan Pharmaceuticals (TTNP) United States $0.028B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
Cleveland BioLabs (CBLI) United States $0.027B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.024B 0.00
Prana Biotechnology (ATHE) Australia $0.021B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
BioCardia (BCDA) United States $0.017B 0.00
Neuralstem (SNCA) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00